Pricing Log in Create free account
Friday 6 November 2026 Export ADMA’s income statement to Excel — free account

ADMA Biologics Inc

ADMA Healthcare Biotechnology

ADMA Biologics Inc’s revenue for fiscal 2025 (year ended December 2025) was $510.2 million, up 19.6% from fiscal 2024.

Revenue
+5.12%
EPS
+46.7%
Free cash flow
+1,709.5%
Total debt
+140.5%

Quarter to September 2026, against a year earlier

13.08 0.13 −0.98%
Market cap
$3.0B
P/E
16.7×
Fwd P/E
14.0×
Dividend yield
—
F-score
5/9
Altman Z
19.98
Beneish M
−0.17
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

ADMA Biologics Inc (ADMA) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, ADMA Biologics Inc (ADMA) trades at a EV/EBITDA of 13.0×. Over the past ten years it has ranged from 0.0× (September 2023) to 93.3× (December 2023); the current reading is higher than 79% of that period. That is above the Biotechnology industry median of 0.7× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 21.7× (19.44%)
FY2024 26.9× (21.36%)
FY2023 34.2× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 10.0× 17.47%
Jun 2026 8.5× (13.49%)
Mar 2026 9.8× (54.76%)
Dec 2025 21.7× 8.19%
43 more quarters

Against its own ten years

Low 0.0× High 93.3×
Ten-year median 0.0×
Current reading's percentile 79

EV/EBITDA against peers

Company EV/EBITDA
PVLA Palvella Therapeutics, Inc. compare n/m
PHVS Pharvaris N.V. compare n/m
BHVN Biohaven Ltd. compare n/m
VERA Vera Therapeutics, Inc. compare n/m
CLDX Celldex Therapeutics, Inc. compare n/m
IMNM Immunome, Inc. compare n/m
AUPH Aurinia Pharmaceuticals Inc compare 10.5×
ADMA ADMA Biologics Inc 13.0×
VCEL Vericel Corporation compare 79.1×
Biotechnology industry median 0.7×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ADMA